Literature DB >> 16782587

Influence of malathion on acetylcholinesterase activity in rats submitted to a forced swimming test.

Zoraide R Ramos1, Jucélia J Fortunato, Fabiano R Agostinho, Márcio R Martins, Maísa Correa, Maria Rosa C Schetinger, Felipe Dal-Pizzol, João Quevedo.   

Abstract

The organophosphorus insecticides, including malathion, are used indiscriminately in large amounts, causing environmental pollution and risk to human health. Classically, this toxicity is attributed mainly to the accumulation of acetylcholine (ACh), due to inhibition of acetylcholinesterase (AChE), and consequently overstimulation of the nicotinic and muscarinic receptors. The present study investigated the effects of acute and chronic malathion administration in immobility time in the forced swimming test (FST), open-field test and AChE activity in neural tissue of rats. Malathion was administered intraperitoneally once a day for one day (acute) or for 28 days (chronic) (in both protocols malathion was administered at 25, 50, 100 and 150 mg/kg). No significant effect was seen in immobility time in the FST after acute malathion treatment. The chronic malathion treatment induced an increase in the time of immobility in the FST. Both treatments do not interfere in locomotor activity evaluated in a novel environment. The inhibition of AChE activity was significant in the hippocampus (25, 50, 100 and 150 mg/kg), cortex (100 and 150 mg/kg) and striatum (150 mg/kg) after chronic treatment, but not significantly after acute treatment. These data suggest a possible interaction between increased immobility time in the FST and activation of cholinergic receptors by accumulated ACh subsequent to AChE inhibition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16782587     DOI: 10.1007/bf03033318

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  27 in total

1.  Antidepressant-like properties of zinc in rodent forced swim test.

Authors:  B Kroczka; P Branski; A Palucha; A Pilc; G Nowak
Journal:  Brain Res Bull       Date:  2001-05-15       Impact factor: 4.077

Review 2.  Neurobehavioral effects of pesticides: state of the art.

Authors:  C Colosio; M Tiramani; M Maroni
Journal:  Neurotoxicology       Date:  2003-08       Impact factor: 4.294

3.  Chronic, low-level exposure to diisopropylfluorophosphate causes protracted impairment of spatial navigation learning.

Authors:  M A Prendergast; A V Terry; J J Buccafusco
Journal:  Psychopharmacology (Berl)       Date:  1997-01       Impact factor: 4.530

4.  Chronic neurobehavioral effects of Tokyo subway sarin poisoning in relation to posttraumatic stress disorder.

Authors:  K Yokoyama; S Araki; K Murata; M Nishikitani; T Okumura; S Ishimatsu; N Takasu; R F White
Journal:  Arch Environ Health       Date:  1998 Jul-Aug

5.  Chronic neurological sequelae of acute organophosphate pesticide poisoning.

Authors:  E P Savage; T J Keefe; L M Mounce; R K Heaton; J A Lewis; P J Burcar
Journal:  Arch Environ Health       Date:  1988 Jan-Feb

Review 6.  Acetylcholinesterase inhibition and the extrapyramidal syndrome: a review of the neurotoxicity of organophosphate.

Authors:  B H Hsieh; J F Deng; J Ger; W J Tsai
Journal:  Neurotoxicology       Date:  2001-08       Impact factor: 4.294

7.  In the rat forced swimming test, chronic but not subacute administration of dual 5-HT/NA antidepressant treatments may produce greater effects than selective drugs.

Authors:  Jean-Philippe Rénéric; Manuel Bouvard; Luis Stinus
Journal:  Behav Brain Res       Date:  2002-11-15       Impact factor: 3.332

8.  An epidemiological study of the relations between exposure to organophosphate pesticides and indices of chronic peripheral neuropathy and neuropsychological abnormalities in sheep farmers and dippers.

Authors:  A Pilkington; D Buchanan; G A Jamal; R Gillham; S Hansen; M Kidd; J F Hurley; C A Soutar
Journal:  Occup Environ Med       Date:  2001-11       Impact factor: 4.402

9.  Sensory neuropathy associated with Dursban (chlorpyrifos) exposure.

Authors:  J G Kaplan; J Kessler; N Rosenberg; D Pack; H H Schaumburg
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

10.  Biological monitoring of combined exposure to organophosphates and pyrethroids.

Authors:  Fengsheng He; Shuyang Chen; Xiaoyong Tang; Wenqi Gan; Bingeng Tao; Baoyuan Wen
Journal:  Toxicol Lett       Date:  2002-08-05       Impact factor: 4.372

View more
  5 in total

1.  Neuroprotective potential of crocin against malathion-induced motor deficit and neurochemical alterations in rats.

Authors:  Leila Mohammadzadeh; Hossein Hosseinzadeh; Khalil Abnous; Bibi Marjan Razavi
Journal:  Environ Sci Pollut Res Int       Date:  2017-12-04       Impact factor: 4.223

2.  Acute and subacute exposure to malathion impairs aversive but not non-associative memory in rats.

Authors:  Samira S Valvassori; Jucélia J Fortunato; Karin M Gomes; Gislaine Z Réus; Márcio R Martins; Elaine C Gavioli; Maria Rosa C Schetinger; Felipe Dal-Pizzol; João Quevedo
Journal:  Neurotox Res       Date:  2007-07       Impact factor: 3.911

3.  Crocin prevents haloperidol-induced orofacial dyskinesia: possible an antioxidant mechanism.

Authors:  Marzyeh Kamyar; Bibi Marjan Razavi; Faezeh Vahdati Hasani; Soghra Mehri; Amir Foroutanfar; Hossein Hosseinzadeh
Journal:  Iran J Basic Med Sci       Date:  2016-10       Impact factor: 2.699

Review 4.  Repurposing Cholinesterase Inhibitors as Antidepressants? Dose and Stress-Sensitivity May Be Critical to Opening Possibilities.

Authors:  Paul J Fitzgerald; Pho J Hale; Anjesh Ghimire; Brendon O Watson
Journal:  Front Behav Neurosci       Date:  2021-01-14       Impact factor: 3.558

5.  Involvement of brain-derived neurotrophic factor (BDNF) on malathion induced depressive-like behavior in subacute exposure and protective effects of crocin.

Authors:  Somaye Ardebili Dorri; Hossein Hosseinzadeh; Khalil Abnous; Faezeh Vahdati Hasani; Rezvan Yazdian Robati; Bibi Marjan Razavi
Journal:  Iran J Basic Med Sci       Date:  2015-10       Impact factor: 2.699

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.